Search results for "mucolipidosi"

showing 6 items of 6 documents

Mucolipidosis I: increased sialic acid content and deficiency of an alpha-N-acetylneuraminidase in cultured fibroblasts.

1977

Abstract Extracts of fibroblasts derived from a patient with mucolipidosis I exhibited a fivefold increase in sialic acid content as compared to those of normal cells. About 80% of this sialic acid was linked to other molecules. Using neuraminlactose as a substrate, mucolipidosis I fibroblasts were found to be severely deficient in an “acid” α-N-acetylneuraminidase. Since other lysosomal hydrolase activities were normal, we hypothesize that the basic metabolic lesion in mucolipidosis I lies in a defective degradation of sialic acid-containing compounds due to the genetic deficiency of a neuraminidase.

BiophysicsNeuraminidaseBiochemistryLesionchemistry.chemical_compoundMucolipidosesMucolipidosis IHydrolasemedicineHumansSialidosisMolecular BiologyCells CulturedSkinbiologyMucolipidosesSubstrate (chemistry)Cell BiologyFibroblastsmedicine.diseaseSialic acidBiochemistrychemistrybiology.proteinSialic Acidsmedicine.symptomNeuraminidaseBiochemical and biophysical research communications
researchProduct

Immunelectronmicroscopic characterization of T4 and T8 lymphocytes and natural killer cells in neuronal ceroid-lipofuscinosis.

1995

CD4+, CD8+, and CD56+ cells were isolated with the immunomagnetic separation technique from peripheral blood mononuclear cells (PBMC) of 3 patients with neuronal ceroid-lipofuscinosis : one patient each with infantile (INCL), late infantile (LINCL), and juvenile (JNCL) neuronal ceroid-lipofuscinoses, all studied by light (LM) and electron (EM) microscopy. To compare the pathology of these cells with affected cells in other types of lysosomal diseases, the separation was also performed with PBMC of 1 patient with mucolipidosis (ML) type II, 2 patients with mucopolysaccharidosis (MPS) type I, and 4 patients with MPS type III. Disease-specific lysosomal inclusions were identified in CD4+, CD8+…

CD4-Positive T-LymphocytesAdolescentMucolipidosisLymphocyteMucopolysaccharidosisInfantBiologyCD8-Positive T-LymphocytesMucopolysaccharidosesmedicine.diseaseImmunomagnetic separationMolecular biologyPeripheral blood mononuclear cellKiller Cells Naturalmedicine.anatomical_structureNeuronal Ceroid-LipofuscinosesChild PreschoolImmunologymedicineHumansNeuronal ceroid lipofuscinosisLysosomesMicroscopy ImmunoelectronGenetics (clinical)CD8American journal of medical genetics
researchProduct

Mucolipidosis I — A sialidosis

1977

Mucolipidosis I is characterized by Hurler-like features and skeletal dysplasia with a cherry-red macular spot and signs of neurodegeneration involving neuronal cells and myelin. Excessive amounts of sialic acid-containing compounds were found in cultured fibroblasts, leukocytes, and urine of a patient with a clinical phenotype of mucolipidosis I. In cultured fibroblasts, profoundly diminished activity of an alpha-N-acetylneuraminidase (sialidase) was found. Mucolipidosis I thus appears to be a distinct disorder of complex carbohydrate catabolism caused by the genetic deficiency of a neuraminidase.

Malemedicine.medical_specialtyHydrolasesNeuraminidaseSialidaseMyelinMucolipidosesInternal medicinemedicineHumansSialidosisChildCells CulturedGenetics (clinical)SkinbiologyMucolipidosisCatabolismNeurodegenerationmedicine.diseasePhenotypeEndocrinologymedicine.anatomical_structureDysplasiaChild PreschoolImmunologySialic Acidsbiology.proteinLysosomesNeuraminidaseFollow-Up StudiesAmerican Journal of Medical Genetics
researchProduct

Oligosaccharide and Ganglioside Neuraminidase Activities of Mucolipidosis I (Sialidosis) and Mucolipidosis II (I-Cell Disease) Fibroblasts

1979

Fibroblasts cultured from the skin of patients with the genetic diseases mucolipidosis I and mucolipidosis II were found deficient in a neuraminidase specific for both an α23 and and α2 6 type of neuraminosyl linkage of sialyl oligosaccharides. Obligate heterozygotes (parents) showed an intermediate activity in mucolipidosis I, but a normal one in mucolipidosis II. The neuraminidase activity of mucolipidosis I fibroblasts towards gangliosides, measured at pH 4.5 in the presence of Triton X-100, was within the range of normal controls with gangliosides Gm3 and GD3, but somewhat diminished with a bovine brain ganglioside preparation. In mucolipidosis II, neuraminidase activity was markedly de…

NeuraminidaseOligosaccharidesBiochemistryCell LinePolyethylene GlycolsSubstrate SpecificityMucolipidosesGangliosidesmedicineHumansGanglioside GD3SialidosisCells CulturedSkinchemistry.chemical_classificationGangliosidebiologyMucolipidosisGenetic Carrier ScreeningHeterozygote advantageFibroblastsOligosaccharidemedicine.diseaseKineticschemistryBiochemistrybiology.proteinlipids (amino acids peptides and proteins)I-cell diseaseNeuraminidaseEuropean Journal of Biochemistry
researchProduct

Artrite o artropatia? Nuova mutazione del gene GNPTG in bambina con mucolipidosi IIIγ

2021

Settore MED/38 - Pediatria Generale E Specialisticamucolipidosi MLIIIγGNPTG
researchProduct

Prenatal diagnosis of mucolipidosis II (I-cell disease)

1976

A pregnancy at risk for mucolipidosis II (I-cell disease) was monitored in which an affected fetus was predicted on the basis of the analyses of lysosomal hydrolases in amniotic fluid and cultured amniotic fluid cells, and by the demonstration of an excessive accumulation of [35S] sulfate-labeled glycosaminoglycans in cultured amniotic cells. This diagnosis was confirmed by performing enzyme assays and [35S] sulfate incorporation studies on material derived from the aborted fetus.

medicine.medical_specialtyAmniotic fluidHydrolasesPrenatal diagnosisSulfur RadioisotopesAndrologyGlycosaminoglycanPregnancyPrenatal DiagnosisInternal medicinemedicineHumansRadiology Nuclear Medicine and imagingCells CulturedGlycosaminoglycansPregnancyFetusbusiness.industryMucolipidosisAborted FetusGeneral MedicineMucopolysaccharidosesAmniotic Fluidmedicine.diseaseEndocrinologyPediatrics Perinatology and Child HealthFemaleI-cell diseaseLysosomesbusinessEuropean Journal of Pediatrics
researchProduct